Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Abiraterone
Abiraterone
154229-19-3
|
349.241
|
5.165
Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1. Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. It is used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer.
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1. Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. It is used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer.
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
$19/5 mg
(EBC)
1
We provide 0 compound for Abiraterone